Výsledky vyhľadávania - "Diabetes Mellitus, Type 2 epidemiology"
-
1
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: AIDS
AIDS, vol. 37, no. 6, pp. 935-939Predmety: Male, 610 Medicine & health, HIV Infections, HIV Infections / complications, Switzerland / epidemiology, 10234 Clinic for Infectious Diseases, HIV Infections / epidemiology, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Humans, Prospective Studies, Obesity, 2. Zero hunger, 2403 Immunology, Diabetes Mellitus, Type 2 / epidemiology, 2725 Infectious Diseases, Clinical Science, 16. Peace & justice, Obesity / complications, 3. Good health, Diabetes Mellitus, Type 2, 2723 Immunology and Allergy, Female, Switzerland, Diabetes Mellitus, Type 2/epidemiology, Switzerland/epidemiology, HIV Infections/complications, HIV Infections/epidemiology, Obesity/complications
Popis súboru: application/pdf; comparison_of_five_different_risk_scores_to.9.pdf - application/pdf
-
2
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Int J Public Health
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
International Journal of Public Health, Vol 68 (2024)Predmety: Adult, Western Europe, Adolescent Health, Diabetes, Global Burden of Disease, Public Health, Adolescent, Àrees temàtiques de la UPC::Ciències de la salut::Medicina::Medicina comunitària i salut pública, Adolescent health, Global Health, Young Adult, SDG 3 - Good Health and Well-being, 11. Sustainability, Prevalence, Humans, Child, 10. No inequality, 2. Zero hunger, Public health, Diabetes Mellitus, Type 2 / epidemiology, global burden of disease, diabetes, Public Health Archive, Incidence, public health, 1. No poverty, Diabetes in youth, adolescent health, 16. Peace & justice, Àrees temàtiques de la UPC::Enginyeria biomèdica, 3. Good health, Diabetes Mellitus, Type 1 / epidemiology, Global burden of disease, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetis juvenil, Quality-Adjusted Life Years, adolescents, western europe, burden of disease, estimates, Public aspects of medicine, RA1-1270
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38420040
https://doaj.org/article/496224d148a9407682f96a0cfe2b055c
https://pure.eur.nl/en/publications/adf0f621-bba4-4c73-b135-d2af7dfc3443
https://doi.org/10.3389/ijph.2023.1606491
https://archive-ouverte.unige.ch/unige:184278
https://doi.org/10.3389/ijph.2023.1606491
https://producciocientifica.uv.es/documentos/661283d9181737381ebceec1?lang=ca
https://doi.org/10.3389/ijph.2023.1606491
https://hdl.handle.net/2117/409998
https://www.ssph-journal.org/journals/international-journal-of-public-health/articles/10.3389/ijph.2023.1606491/full
https://doi.org/10.3389/ijph.2023.1606491
https://hdl.handle.net/11585/996280 -
3
Autori: a ďalší
Zdroj: Diabetes Obes Metab
Predmety: Antidiabetic drug, Sodium-Glucose Transporter 2 Inhibitors / therapeutic use, 03 medical and health sciences, 0302 clinical medicine, Hypoglycemic Agents / therapeutic use, Risk Factors, Glucagon-Like Peptide 1, Diabetes Mellitus, Type 2 / complications, Humans, Hypoglycemic Agents, Glucagon-Like Peptide 1 / therapeutic use, Sodium-Glucose Transporter 2 Inhibitors, Cardiovascular Diseases / epidemiology, Diabetes Mellitus, Type 2 / epidemiology, SGLT2 inhibitor, Type 2 diabetes, Glucose / therapeutic use, Glucagon-Like Peptide-1 Receptor / agonists, Original Articles, Cardiovascular Diseases / chemically induced, Cardiovascular disease, 3. Good health, Cross-Sectional Studies, Glucose, Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor Agonists, Cardiovascular Diseases, Heart Disease Risk Factors, GLP-1, Diabetes Mellitus, Type 2 / drug therapy, Cardiovascular Diseases / prevention & control
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/36199242
-
4
Autori: a ďalší
Zdroj: International Journal of Cardiology. 365:8-18
Predmety: Glucagon-Like Peptide 1 / metabolism, Diabetes Mellitus, Type 2* / epidemiology, 03 medical and health sciences, 0302 clinical medicine, Hypoglycemic Agents / therapeutic use, Glucagon-Like Peptide 1, Diabetes Mellitus, Type 2* / diagnosis, Diabetes Mellitus, Type 2* / drug therapy, Liraglutide / therapeutic use, Cardiovascular Diseases* / epidemiology, Humans, Hypoglycemic Agents, Type 2 diabetes mellitus, Liraglutide / pharmacology, GLP-1 receptor agonists, Glucagon-Like Peptide-1 Receptor / agonists, Cardiovascular Diseases* / drug therapy, Liraglutide, Algorithm, Cardiovascular outcomes trials, Treatment, 3. Good health, Hypoglycemic Agents / pharmacology, Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor Agonists, Cardiovascular Diseases, Algorithm, Cardiovascular outcomes trials, GLP-1 receptor agonists, Treatment, Type 2 diabetes mellitus, HCC END
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/35905827
http://hdl.handle.net/10400.17/4835 -
5
Autori: a ďalší
Zdroj: Sci Rep
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)Predmety: diabetes mellitus type 2, dipeptidyl-peptidase 4 inhibitors, insulin, Substances, COVID-19 Vaccines, Science, hypoglycemic agents, COVID-19 Vaccines / therapeutic use, Cardiomyopathies / chemically induced, Sodium-Glucose Transporter 2 Inhibitors / therapeutic use, Article, 03 medical and health sciences, Diabetes mellitus type 2, 0302 clinical medicine, Hypoglycemic agents, Hypoglycemic Agents / therapeutic use, Sodium-glucose transporter 2 inhibitors, sodium-glucose transporter 2 inhibitors, Diabetes Mellitus, Type 2 / complications, pioglitazone, Humans, Hypoglycemic Agents, Insulin, Sulfonylurea Compounds / therapeutic use, Sodium-Glucose Transporter 2 Inhibitors, COVID-19 / complications, Retrospective Studies, repaglinide, Dipeptidyl-Peptidase IV Inhibitors, Diabetes Mellitus, Type 2 / epidemiology, SARS-CoV-2, COVID-19, Dipeptidyl-Peptidase IV Inhibitors / therapeutic use, Insulin / therapeutic use, 3. Good health, Sulfonylurea Compounds, Diabetes Mellitus, Type 2, Dipeptidyl-peptidase 4 inhibitors, sulfonylurea compounds, Medicine, Diabetes Mellitus, Type 2 / drug therapy, metformin, Cardiomyopathies, acarbose
Popis súboru: application/pdf
-
6
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: The Lancet Diabetes & Endocrinology. 9:825-836
Predmety: Blood Glucose, Heart Failure, Diabetes Mellitus, Type 2 / epidemiology, Cost-Benefit Analysis, 1. No poverty, Insulin Glargine, Glucagon-Like Peptide-1 Receptor / agonists, Insulin / therapeutic use, Sodium-Glucose Transporter 2 Inhibitors / therapeutic use, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor Agonists, Hypoglycemic Agents / therapeutic use, Blood Glucose / metabolism, Humans, Hypoglycemic Agents, Insulin, Insulin Glargine / therapeutic use, Diabetes Mellitus, Type 2 / drug therapy, Developing Countries, Sodium-Glucose Transporter 2 Inhibitors, Heart Failure / drug therapy
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/34656210
https://research.birmingham.ac.uk/portal/en/publications/expanding-access-to-newer-medicines-for-people-with-type -2 -diabetes -mellitus -in-low-and-middleincome-countries(80562337-34e7-4c4d-be07-c75e6ea2ef0e).html -
7
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Diabetes Care
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de MadridPredmety: Cardiovascular and Metabolic Risk, Type 2* / epidemiology Double-Blind Method Humans Lipoprotein(a) Proprotein Convertase 9 Treatment Outcome, Anticholesteremic Agents, Antibodies, Monoclonal, Humanized, Antibodies, 3. Good health, 03 medical and health sciences, Type 2* / drug therapy Diabetes Mellitus, Treatment Outcome, 0302 clinical medicine, Diabetes Mellitus, Type 2, Double-Blind Method, Humanized Anticholesteremic Agents* Diabetes Mellitus, Monoclonal, Diabetes Mellitus, Humans, Proprotein Convertase 9, Humanized, Type 2, Antibodies, Monoclonal, Humanized Anticholesteremic Agents* Diabetes Mellitus, Type 2* / drug therapy Diabetes Mellitus, Type 2* / epidemiology Double-Blind Method Humans Lipoprotein(a) Proprotein Convertase 9 Treatment Outcome, Lipoprotein(a)
Popis súboru: application/pdf
Prístupová URL adresa: https://figshare.com/articles/figure/Relation_of_Lipoprotein_a_Levels_to_Incident_Type_2_Diabetes_and_Modification_by_Alirocumab_Treatment/13805825/1/files/26750645.pdf
https://care.diabetesjournals.org/content/diacare/44/5/1219.full.pdf
https://escholarship.org/content/qt5h6931kv/qt5h6931kv.pdf?t=qq3qeq
https://pubmed.ncbi.nlm.nih.gov/33722880
https://hdl.handle.net/20.500.12530/59518
https://escholarship.org/uc/item/5h6931kv
https://www.ncbi.nlm.nih.gov/pubmed/33722880
https://researchnow.flinders.edu.au/en/publications/relation-of-lipoproteina-levels-to-incident-type -2 -diabetes -and-m
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132323
https://escholarship.org/content/qt5h6931kv/qt5h6931kv.pdf?t=qq3qeq
http://care.diabetesjournals.org/content/early/2021/03/10/dc20-2842
https://hdl.handle.net/1887/3274114
https://escholarship.org/uc/item/5h6931kv -
8
Autori: a ďalší
Zdroj: Сахарный диабет, Vol 23, Iss 5, Pp 404-411 (2021)
Predmety: 2. Zero hunger, 03 medical and health sciences, RC620-627, 0302 clinical medicine, diabetes mellitus type 2, epidemiology, diagnosis, Nutritional diseases. Deficiency diseases, 3. Good health
-
9
Autori: a ďalší
Zdroj: Revue Médicale Suisse. 17:1062-1066
Predmety: Adult, Diabetes Mellitus, Type 2 / genetics, 03 medical and health sciences, Diabetes Mellitus, Type 2 / epidemiology, Hepatocyte Nuclear Factor 4 / genetics, 0302 clinical medicine, Diabetes Mellitus, Type 2 / diagnosis, Glucokinase / genetics, Mutation, Humans
Popis súboru: application/pdf
-
10
Autori: a ďalší
Zdroj: Revue Médicale Suisse. 17:1087-1090
Predmety: Patient Transfer, Transition hôpital-ambulatoire, Patient diabétique, Ambulatoire, Diabetes Mellitus, Type 2 / epidemiology, Continuity of Patient Care, Diabetes Mellitus, Type 2 / therapy, Hospitals, Patient Discharge, 03 medical and health sciences, Retour à domicile, 0302 clinical medicine, Hospitalisation, Humans
Popis súboru: application/pdf
-
11
Autori:
Zdroj: Revue médicale suisse, Vol. 17, No 723 (2021) pp. 188-191
Revue médicale suisse, Vol. 16, No 676-7 (2020) pp. 31-33Predmety: ddc:616, Diabétologie, Diabetes Mellitus, Type 2 / epidemiology, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Inhibiteurs du SGLT2, Analogue du GLP-1, Hypoglycemic Agents/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors / therapeutic use, Glucagon-Like Peptide-1 Receptor, Metformin, 3. Good health, Hypoglycemic Agents / therapeutic use, General Practitioners, Diabetes Mellitus, Humans, Diabetes Mellitus, Type 2 / drug therapy, Type 2/drug therapy/epidemiology, Type 2/diagnosis/drug therapy
Popis súboru: application/pdf
-
12
Autori: a ďalší
Zdroj: Nat Commun
Nature Communications, Vol 13, Iss 1, Pp 1-9 (2022)
Anza-Ramirez, C, Lazo, M, Zafra-Tanaka, J H, Avila-Palencia, I, Bilal, U, Hernández-Vásquez, A, Knoll, C, Lopez-Olmedo, N, Mazariegos, M, Moore, K, Rodriguez, D A, Sarmiento, O L, Stern, D, Tumas, N & Miranda, J J 2022, 'The urban built environment and adult BMI, obesity, and diabetes in Latin American cities', Nature Communications, vol. 13, no. 1, 7977. https://doi.org/10.1038/s41467-022-35648-w
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
Nature CommunicationsPredmety: Adult, CITIES, Science, Latin America - epidemiology, Cities - epidemiology, LATIN AMERICA, Article, Body Mass Index, BMI, 03 medical and health sciences, 0302 clinical medicine, 11. Sustainability, Diabetes Mellitus, Obesity - epidemiology, Humans, DIABETES, name=SDG 3 - Good Health and Well-being, Obesity, Cities, Built Environment, 2. Zero hunger, Diabetis, Diabetes, 1. No poverty, Diabetes Mellitus, Type 2 - epidemiology, Type 2 - epidemiology, 3. Good health, BUILT ENVIRONMENT, Latin America, Diabetes Mellitus, Type 2, OBESITY, Obesitat, Amèrica Llatina
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/36581636
https://doaj.org/article/71653225bb084275a023c31fa452b7cc
https://pure.qub.ac.uk/en/publications/2836180f-903c-4c6a-be2c-e66125a901cc
http://hdl.handle.net/11336/214944
https://hdl.handle.net/20.500.12866/13000
https://doi.org/10.1038/s41467-022-35648-w -
13
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: BMC Public Health
BMC Public Health, Vol 22, Iss 1, Pp 1-9 (2022)Predmety: Adult, Male, Blood Glucose, Adult population, Mozambique, National survey, NCD, Prevalence, Sub-Saharan Africa, Trend analysis, Type 2 diabetes, 03 medical and health sciences, 0302 clinical medicine, 11. Sustainability, Humans, Obesity, Obesity / epidemiology, 2. Zero hunger, Diabetes Mellitus, Type 2 / epidemiology, Research, 1. No poverty, Diabetes Mellitus, Type 2 / therapy, 3. Good health, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Blood Glucose / analysis, Mozambique / epidemiology, Female, Public aspects of medicine, RA1-1270
Popis súboru: application/pdf
-
14
Autori: a ďalší
Zdroj: Acta Diabetol
Predmety: Croatia / epidemiology, Adult, Male, Attitude of Health Personnel, Croatia, Guideline Adherence / standards, Decision Making, Slovenia, Time-to-Treatment, Surveys and Questionnaires, Slovenia / epidemiology, Practice Patterns, Physicians' / statistics & numerical data, Humans, Insulin, Time-to-Treatment / statistics & numerical data, Europe, Eastern, Practice Patterns, Physicians', Bulgaria, Type 2 diabetes mellitus, Hungary, Diabetes Mellitus, Type 2 / epidemiology, Greece / epidemiology, Insulin therapy initiation, Greece, Middle Aged, Insulin / therapeutic use, Hungary / epidemiology, 3. Good health, Clinical inertia, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Europe, Eastern / epidemiology, Guideline Adherence / statistics & numerical data, Original Article, Female, Guideline Adherence, Diabetes Mellitus, Type 2 / drug therapy, Bulgaria / epidemiology
Popis súboru: application/pdf
Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00592-019-01346-1.pdf
https://pubmed.ncbi.nlm.nih.gov/30993528
https://www.bib.irb.hr/1260056
https://doi.org/10.1007/s00592-019-01346-1
https://link.springer.com/article/10.1007/s00592-019-01346-1
https://eprints.whiterose.ac.uk/144886/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675753
https://europepmc.org/article/MED/30993528
https://pubmed.ncbi.nlm.nih.gov/30993528/
https://paperity.org/p/192801660/high-level-of-clinical-inertia-in-insulin-initiation-in-type -2 -diabetes -across-central
http://doi.org/10.1007/s00592-019-01346-1 -
15
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Obesity Facts, Vol 12, Iss 6, Pp 639-652 (2019)
Predmety: Male, Diabetes Mellitus, Type 2 / surgery, Bariatric Surgery, Comorbidity, Obesity, Morbid / complications, 0302 clinical medicine, Weight Loss / physiology, Metabolic Syndrome / complications, Laparoscopy / methods, TX341-641, Metabolic Syndrome / epidemiology, Nutritional diseases. Deficiency diseases, Metabolic Syndrome, 2. Zero hunger, Gastrectomy / statistics & numerical data, Remission Induction, Age Factors, Middle Aged, Obesity, Morbid, 3. Good health, Treatment Outcome, Obesity, Morbid / surgery, Gastric Bypass / methods, Female, Adult, RC620-627, Gastrectomy / methods, Gastric Bypass / statistics & numerical data, bariatric surgery, Metabolic Syndrome / surgery, Gastric Bypass, metabolic syndrome, Bariatric Surgery / statistics & numerical data, 03 medical and health sciences, Sex Factors, Gastrectomy, Weight Loss, Diabetes Mellitus, Type 2 / complications, Humans, Obesity, Morbid / epidemiology, Retrospective Studies, Diabetes Mellitus, Type 2 / epidemiology, Bariatric Surgery / methods, Nutrition. Foods and food supply, morbid obesity, Laparoscopy / statistics & numerical data, Diabetes Mellitus, Type 2, Laparoscopy, weight loss, Follow-Up Studies
Popis súboru: application/pdf
Prístupová URL adresa: https://www.karger.com/Article/Pdf/503753
https://pubmed.ncbi.nlm.nih.gov/31747662
https://doaj.org/article/1972e8c70f75494088bc13fe82b405fa
https://www.ncbi.nlm.nih.gov/pubmed/31747662
https://doaj.org/article/1972e8c70f75494088bc13fe82b405fa
https://pubmed.ncbi.nlm.nih.gov/31747662/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940448
https://europepmc.org/article/MED/31747662
https://hdl.handle.net/10216/138977 -
16
Autori: a ďalší
Zdroj: PLoS One
PLoS ONE, Vol 19, Iss 3 (2024)Predmety: COVID-19 Vaccines, Renal Insufficiency, Chronic / epidemiology, Science, hypoglycemic agents, COVID-19 Vaccines / therapeutic use, Sodium-Glucose Transporter 2 Inhibitors / therapeutic use, COVID-19 / epidemiology, 03 medical and health sciences, 0302 clinical medicine, Piperidines, Hypoglycemic Agents / therapeutic use, Renal Insufficiency, Chronic / drug therapy, Diabetes Mellitus, Type 2 / complications, Metformin / therapeutic use, Humans, Hypoglycemic Agents, Insulin, Sulfonylurea Compounds / therapeutic use, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, COVID-19 / complications, Retrospective Studies, Diabetes Mellitus, Type 2 / epidemiology, Renal Insufficiency, Chronic / complications, SARS-CoV-2, COVID-19, Insulin / therapeutic use, Metformin, 3. Good health, Sulfonylurea Compounds, type 2, Diabetes Mellitus, Type 2, diabetes mellitus, Medicine, Carbamates, Diabetes Mellitus, Type 2 / drug therapy, Research Article
Popis súboru: application/pdf
-
17
Autori: a ďalší
Zdroj: Tidsskrift for Den Norske Laegeforening. 139(18):1750
-
18
Autori: a ďalší
Zdroj: Nordic Journal of Psychiatry. 72(7):455
-
19
Autori: Videhult, Per
Zdroj: Läkartidningen. 115(1-2):24
-
20
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Clinical Infectious Diseases, Vol. 45, No 1 (2007) pp. 111-119
Clinical Infectious Diseases, vol. 45, no. 1, pp. 111-9Predmety: Adult, Male, Adult Anti-HIV Agents/therapeutic use Antiretroviral Therapy, Highly Active Cohort Studies Diabetes Mellitus, Type 2/*epidemiology/etiology Female HIV Infections/*complications/drug therapy Humans Incidence Male Middle Aged Risk Factors Sweden/epidemiology, Anti-HIV Agents, 610 Medicine & health, HIV Infections, 142-005 142-005, 2726 Microbiology (medical), Cohort Studies, 03 medical and health sciences, Switzerland/epidemiology, 0302 clinical medicine, Risk Factors, Antiretroviral Therapy, Highly Active, Humans, ddc:616, Incidence, 2725 Infectious Diseases, Middle Aged, 16. Peace & justice, Diabetes Mellitus, Type 2/ epidemiology/etiology, HIV Infections/ complications/drug therapy, 3. Good health, Diabetes Mellitus, Type 2, Anti-HIV Agents/therapeutic use, Female, Switzerland
Popis súboru: application/pdf; ZORA_NL_155614.pdf - application/pdf
Prístupová URL adresa: https://academic.oup.com/cid/article-pdf/45/1/111/1297052/45-1-111.pdf
https://pubmed.ncbi.nlm.nih.gov/17554711
https://paperity.org/p/42879676/factors-associated-with-the-incidence-of-type -2 -diabetes -mellitus -in-hiv-infected
https://archive-ouverte.unige.ch/unige:7402
http://cid.oxfordjournals.org/content/45/1/111.full
https://academic.oup.com/cid/article-pdf/45/1/111/1297052/45-1-111.pdf
https://www.zora.uzh.ch/id/eprint/155614/1/ZORA_NL_155614.pdf
https://www.mendeley.com/catalogue/6b75183e-a134-3caa-80d9-9d8d4469f117/
https://archive-ouverte.unige.ch/unige:7402
https://doi.org/10.1086/518619
https://archive-ouverte.unige.ch/unige:7402
https://serval.unil.ch/resource/serval:BIB_E584D58FCD72.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_E584D58FCD72
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_E584D58FCD729
http://doc.rero.ch/record/290188/files/45-1-111.pdf
https://www.zora.uzh.ch/id/eprint/155614/
https://doi.org/10.5167/uzh-155614
Full Text Finder
Nájsť tento článok vo Web of Science